Rilzabrutinib for sickle-cell disease pain episodes
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests an oral medicine called rilzabrutinib to see if it can reduce painful episodes in people with sickle-cell disease. It may be an option if you have regular pain crises and are looking for a new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have sickle-cell disease.
- You've had between 2 and 10 painful episodes (VOCs) in the last year.
- You are either not taking hydroxyurea or L-glutamine, or you have been taking them stably for at least 6 months.
- You must be able to do most daily activities (ECOG score 0–2).
- You must not have had a stroke or abnormal brain blood flow.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether crizanlizumab can reduce painful sickle cell crises (called vaso-occlusive crises or VOCs) in people with sickle cell disease who have frequent crises. It may be an option for those who still have crises despite current treatments.
This study tests an experimental pill called etavopivat for people with sickle cell disease who have had some pain crises in the past year. The goal is to see if it reduces these crisis episodes.
This trial tests if cannabidiol (CBD) can help reduce pain interference in adults with sickle cell disease. You will take CBD daily for 4 weeks and report your pain levels.
This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.
This study tests a new medicine called anumigilimab to see if it is safe for people with sickle cell disease. The study focuses on those who have had pain crises recently, to help manage and prevent them.
This trial tests an IV medication called L-citrulline for children, teens, and young adults (ages 6–21) with sickle cell disease who are having a sudden, severe pain crisis (called a vaso-occlusive crisis). The goal is to see if it helps relieve pain quickly.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.